BMS Canada relocates employees

Bristol-Myers Squibb Canada is relocating 200 employees to the country's largest technological park located in Montreal, Quebec. The park will be completed by the end of this month. "The Technoparc was the optimal choice for us. As a true hub for R&D in Canada, the Technoparc reflects Bristol-Myers Squibb Canada's commitment to improving the health of Canadians through innovation," said Wayne Quigley, president and general manager of Bristol-Myers Squibb Canada. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.